Is there a role for routine surveillance endotracheal aspirate cultures in the treatment of BAL-confirmed ventilator-associated pneumonia?

Chest

Volumn 127, Issue 2, 2005, Pages 425-427

  Nopmaneejumruslers, Cherdchai ^a,b   Chan, Charles K N ^a,c,d  

^a University of Toronto ^*  (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC;

ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BACTERIUM CULTURE; DIAGNOSTIC ACCURACY; EDITORIAL; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; PATIENT MONITORING; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRACHEOBRONCHIAL TOILET; TREATMENT OUTCOME; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 13644253158     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.127.2.425     Document Type: Editorial

References (13)

1. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control 1999; 27:520-532
2. Centers for Disease Control and Prevention. Monitoring hospital-acquired infections to promote patient safety: United States, 1990-1999. MMWR Morb Mortal Wkly Rep 2000; 49:149-153
3. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe: results of the European Prevalence of Infection in Intensive Care (EPIC) Study; EPIC International Advisory Committee JAMA 1995; 274:639-644
4. Jarvis WR. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost, and prevention. Infect Control Hosp Epidemiol 1996; 17:552-557
5. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903
6. Torres A, Puig de la Bellacasa J, Xaubet A, et al. Diagnostic-value of quantitative cultures of bronchoalveolar lavage and telescoping plugged catheters in mechanically ventilated patients with bacterial pneumonia. Am Rev Respir Dis 1989; 140:306-310
7. Torres A, Carlet J. Ventilator-associated pneumonia: European Task Force on ventilator-associated pneumonia. Eur Respir J 2001; 17:1034-1045
8. Torres A, Martos A, Puig de la Bellacasa J, et al. Specificity of endotracheal aspiration, protected specimen brush, and bronchoalveolar lavage in mechanically ventilated patients. Am Rev Respir Dis 1993; 147:952-957
9. Marquette CH, Georges H, Wallet F, et al. Diagnostic efficiency of endotracheal aspirates with quantitative bacterial cultures in intubated patients with suspected pneumonia: comparison with the protected specimen brush. Am Rev Respir Dis 1993; 148:138-144
10. Dupont H, Mentec H, Sollet JP, et al. Impact of appropriateness of initial antibiotic therapy on the outcome of ventilator-associated pneumonia. Intensive Care Med 2001; 27:355-362
11. Rello J, Gallego M, Mariscal D, et al. The value of routine microbial investigation in ventilator-associated pneumonia. Am J Respir Crit Care Med 1997; 156:196-200
12. Luna CM, Vujacich P, Niederman MS, et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest 1997; 111:676-685
13. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med 2001; 134:298-314